Tricentis Acquires Tx3 Digital Validation Platform for Life Sciences
Extends Critical Software Testing Capabilities to Life Sciences and Healthcare Organizations AUSTIN, Texas–(BUSINESS WIRE)–Tricentis, a…
Extends Critical Software Testing Capabilities to Life Sciences and Healthcare Organizations AUSTIN, Texas–(BUSINESS WIRE)–Tricentis, a…
Introduces Attractive Long-term Net Revenue, Adjusted EBITDA, and EPS Growth Algorithm LENEXA, Kan.–(BUSINESS WIRE)–Hostess Brands,…
Warwick, U.K, 1st March 2022 – Telent is continuing its collaboration with North Wales Fire…
Recognition Follows Acquisition of Printix, a Cloud-Native SaaS Print Management Software Provider Irvine, CA –…
GDPR-compliant information management system will provide HR team with easy online access to hundreds of…
∙ The RNA Printer® is CureVac’s integrated and automated manufacturing solution for RNA vaccines and…
CAMBRIDGE, Mass. and GOSSELIES, Belgium, March 01, 2022 (GLOBE NEWSWIRE) — iTeos Therapeutics, Inc. (Nasdaq:…
WATERTOWN, Mass., March 01, 2022 (GLOBE NEWSWIRE) — EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a pharmaceutical…
Industry Leading Peripheral Nerve Stimulator Upgraded to Improve Patient User Experience with Control of their…
– Former Array BioPharma and Pfizer Executive Joins Dyve Biosciences – CAMARILLO, Calif., March 01,…
— Preparations continue for U.S. commercial launch in June 2022 in BBS and Alström syndrome,…
SAN MATEO, Calif. and CAMBRIDGE, Mass., March 01, 2022 (GLOBE NEWSWIRE) — Kronos Bio, Inc….
Eight abstracts accepted for poster presentation featuring new data from the Phase 3 REST-ON clinical…
CAMBRIDGE, Mass., March 01, 2022 (GLOBE NEWSWIRE) — Walden Biosciences, Inc. (Walden), a private, venture-backed…
20-year corporate finance career spans several pharmaceutical and healthcare-focused companies and underscores financial leadership abilities…
BOSTON, March 01, 2022 (GLOBE NEWSWIRE) — Ikena Oncology, Inc. (Nasdaq: IKNA), a targeted oncology…
BOSTON, March 01, 2022 (GLOBE NEWSWIRE) — Akouos, Inc. (“Akouos”) (NASDAQ: AKUS), a precision genetic…
NEW YORK, March 01, 2022 (GLOBE NEWSWIRE) — Applied Therapeutics, Inc. (Nasdaq: APLT), a clinical-stage…
PHILADELPHIA, March 01, 2022 (GLOBE NEWSWIRE) — Amicus Therapeutics (Nasdaq: FOLD) today announced that members…
– TEMBEXA RFP Response Submitted and Under Review with BARDA – – Pre-Clinical CMX521 Data…